Investment
Features
FeesSafety
Academy
More
Pluang+

Dream Finders Homes expands Reverie brand to include resort lifestyle communities beyond age restrictions

Market News
18 Aug 2026
PRNewsWire
View Source
Bullish
pluang ai news

Dream Finders Homes is broadening its Reverie brand from exclusively age-restricted active adult communities to include both active adult and Resort Lifestyle communities. This shift responds to changing buyer preferences that prioritize wellness, social connection, and flexible living over age-based definitions. The new approach maintains Reverie's focus on lifestyle pillars—Connect, Explore, Thrive—while adapting to market demands by offering communities with and without formal age restrictions. Moving forward, Reverie will emphasize hospitality-driven amenities, wellness, and social engagement to attract buyers seeking a lifestyle rather than an age group.

More News

Grocery Outlet posts Q2 revenue growth and beats EPS forecasts amid strategic restructuring.

Grocery Outlet posts Q2 revenue growth and beats EPS forecasts amid strategic restructuring.

Grocery Outlet Holding Corp. reported a 1.1% revenue increase to $1.19 billion in Q2 2026 and an adjusted EPS of $0.20, beating analyst expectations despite a 13% EPS decline. The company is undergoing strategic restructuring, including closing 36 un...

Company Fundamentals
Bullish
2 hours ago
Hesai posts revenue beat and 60% net income growth despite EPS miss in Q2 2026

Hesai posts revenue beat and 60% net income growth despite EPS miss in Q2 2026

Hesai Group reported Q2 2026 earnings with revenue of $126.9 million, slightly above expectations, driven by strong LiDAR sales. Despite an EPS of $0.01 missing the $0.08 estimate, the company achieved its fifth consecutive GAAP profitable quarter, w...

Company Fundamentals
Bullish
2 hours ago
Amylyx Pharma shares jump 54% on positive Phase 3 trial for avexitide reducing hypoglycemia.

Amylyx Pharma shares jump 54% on positive Phase 3 trial for avexitide reducing hypoglycemia.

Amylyx Pharmaceuticals' stock surged 54.43% after its drug avexitide showed positive Phase 3 trial results, cutting hypoglycemic events by 55% in post-bariatric patients. UBS set a $45 price target, implying a 36% upside from current levels. The stoc...

Market News
Bullish
4 hours ago
IM Cannabis to consolidate shares 30-for-1 to meet Nasdaq $1 minimum bid price by Oct 2026

IM Cannabis to consolidate shares 30-for-1 to meet Nasdaq $1 minimum bid price by Oct 2026

IM Cannabis Corp. announced a 30-for-1 share consolidation effective around August 27, 2026, aiming to increase its stock price and comply with Nasdaq's $1 minimum bid price rule by October 6, 2026. The consolidation will reduce outstanding shares fr...

Company Fundamentals
Neutral
4 hours ago
Ondas boosts growth with Aran Defense acquisition and strong Q2 revenue, raising 2026 outlook.

Ondas boosts growth with Aran Defense acquisition and strong Q2 revenue, raising 2026 outlook.

Ondas is expanding its market and technology through acquiring Aran Defense Ltd., enhancing its autonomous and defense systems. The company reported record Q2 revenue of $83.8 million, up 67% from the previous quarter and over 13 times year-over-year...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App